Latest filing published 23 Jan 2017 for Opko Health, INC., €39k.
Based on 14 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Robert A. Baron across 2 companies, led by Opko Health, Inc. and Nanosensors Inc. Over a trading history stretching from 22 August 2006 to 19 January 2017, the count stands at 48 filings.
Both buying and selling appear: 15 purchases worth €251k, against 11 sales worth €615k. The net balance comes to €364k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants and 17 option exercises.
Half of the purchases are above €5,803 and half below. After 14 purchases with a full 90-day history, the hit rate stands at 36% and the median 90-day move at -2.9%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 23 January 2017, the filings show an option exercise worth €39k in Opko Health, Inc. The most recent open-market purchase was published on 30 June 2015, 4,134 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations